AR114086A2 - Polvos para reconstitución - Google Patents
Polvos para reconstituciónInfo
- Publication number
- AR114086A2 AR114086A2 ARP190100128A ARP190100128A AR114086A2 AR 114086 A2 AR114086 A2 AR 114086A2 AR P190100128 A ARP190100128 A AR P190100128A AR P190100128 A ARP190100128 A AR P190100128A AR 114086 A2 AR114086 A2 AR 114086A2
- Authority
- AR
- Argentina
- Prior art keywords
- reconstitution
- powders
- refers
- water soluble
- soluble polymers
- Prior art date
Links
- 239000000843 powder Substances 0.000 title abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 abstract 1
- YIBOMRUWOWDFLG-ONEGZZNKSA-N rilpivirine Chemical compound CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC=2C=CC(=CC=2)C#N)=N1 YIBOMRUWOWDFLG-ONEGZZNKSA-N 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente se refiere a polvos para reconstitución que comprenden el NNRTI TMC278 disperso en ciertos polímeros solubles en agua, que puede aplicarse en el tratamiento contra la infección por HIV.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07104082 | 2007-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR114086A2 true AR114086A2 (es) | 2020-07-22 |
Family
ID=38055251
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080101032A AR065720A1 (es) | 2007-03-14 | 2008-03-13 | Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso. |
ARP190100128A AR114086A2 (es) | 2007-03-14 | 2019-01-21 | Polvos para reconstitución |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080101032A AR065720A1 (es) | 2007-03-14 | 2008-03-13 | Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso. |
Country Status (18)
Country | Link |
---|---|
US (1) | US8916558B2 (es) |
EP (1) | EP2043608B1 (es) |
JP (1) | JP5554571B2 (es) |
KR (1) | KR101580297B1 (es) |
CN (1) | CN101636149B (es) |
AP (1) | AP2964A (es) |
AR (2) | AR065720A1 (es) |
AU (1) | AU2008225774B2 (es) |
BR (1) | BRPI0808897B8 (es) |
CA (1) | CA2676981C (es) |
CL (1) | CL2008000746A1 (es) |
ES (1) | ES2535162T3 (es) |
IL (1) | IL199874A (es) |
MX (1) | MX2009009743A (es) |
RU (1) | RU2477133C2 (es) |
TW (1) | TWI494133B (es) |
WO (1) | WO2008110619A1 (es) |
ZA (1) | ZA200906344B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
TWI494133B (zh) | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | 重組用粉末 |
CN108210469A (zh) | 2011-04-15 | 2018-06-29 | 詹森药业有限公司 | 冻干药物纳米混悬剂 |
JP6301339B2 (ja) * | 2012-09-27 | 2018-03-28 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 少なくとも1種の水溶性ビタミンe誘導体および少なくとも1種の親水性ポリマーを含む、保存において安定な無塵の均質な粒子製剤 |
EP3993799A1 (en) * | 2019-07-03 | 2022-05-11 | Janssen Sciences Ireland Unlimited Company | Methods of treating hiv in pediatric patients with rilpivirine |
CN113440529B (zh) * | 2020-03-25 | 2023-11-14 | 江苏恒瑞医药股份有限公司 | 一种可注射的药物组合物及其制备方法 |
CN114392241B (zh) * | 2022-01-10 | 2023-07-25 | 安徽贝克生物制药有限公司 | 一种利匹韦林片及其制备方法 |
TW202406551A (zh) * | 2022-04-22 | 2024-02-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 冷凍乾燥組成物(一) |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3089818A (en) * | 1960-06-02 | 1963-05-14 | Baxter Laboratories Inc | Water dispersible antibiotics |
US5182111A (en) * | 1987-11-17 | 1993-01-26 | Boston University Research Foundation | In vivo delivery of active factors by co-cultured cell implants |
US5368864A (en) * | 1988-11-25 | 1994-11-29 | Henning Berlin Gmbh Chemie- Und Pharmawerk | Formulation of oxypurinol and/or its alkali and alkaline earth salts |
US5316773A (en) | 1990-07-19 | 1994-05-31 | Otsuka Pharmaceutical Co., Ltd. | Particulate preparation containing a flourracil derivative and hydroxypropylmethyl-cellulose |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
CA2121129A1 (en) * | 1991-10-29 | 1993-05-13 | Patrick Soon-Shiong | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
AU4079593A (en) | 1992-05-13 | 1993-12-13 | Wellcome Foundation Limited, The | Therapeutic combinations |
JPH06316524A (ja) | 1992-09-11 | 1994-11-15 | Naoyuki Inoue | 抗エイズウイルス剤 |
TW401303B (en) | 1994-07-01 | 2000-08-11 | Janssen Pharmaceutica Nv | Anti-HIV triple combination |
US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
CA2383233C (en) | 1999-09-21 | 2010-06-08 | Rtp Pharma Inc. | Surface modified particulate compositions of biologically active substances |
CZ300712B6 (cs) * | 1999-09-24 | 2009-07-22 | Janssen Pharmaceutica N. V. | Cásticová farmaceutická kompozice, pevná disperze a farmaceutická dávková forma, zpusoby jejich prípravy a použití a obchodní balení s jejich obsahem |
US6743446B2 (en) * | 1999-12-15 | 2004-06-01 | The Ohio State University Research Foundation | Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers |
TWI284048B (en) * | 2000-01-27 | 2007-07-21 | Zentaris Ag | Compressed microparticles for dry injection |
RU2239435C2 (ru) | 2000-03-30 | 2004-11-10 | Бристол-Маерс Сквибб Компани | Гранулы пролонгированного высвобождения, содержащие ставудин |
US20040115268A1 (en) * | 2000-04-26 | 2004-06-17 | Control Delivery Systems, Inc. | Systemic delivery of antiviral agents |
DE10050199A1 (de) | 2000-10-11 | 2002-04-25 | Ethicon Gmbh | Flächiges Implantat mit im Ultraschall detektierbaren Elementen |
AU2002221096A1 (en) | 2000-12-11 | 2002-06-24 | Takeda Chemical Industries Ltd. | Medicinal compositions improved in solublity in water |
BR0210518A (pt) | 2001-06-22 | 2004-06-22 | Pfizer Prod Inc | Composições farmacêuticas de dispersões de drogas e polìmeros neutros |
JO3429B1 (ar) * | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
MY169670A (en) * | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
WO2003043586A2 (en) | 2001-11-20 | 2003-05-30 | Advanced Inhalation Research, Inc. | Compositions for sustained action product delivery |
CA2493794C (en) | 2002-08-09 | 2010-05-25 | Janssen Pharmaceutica N.V. | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
AU2003278766A1 (en) * | 2002-09-04 | 2004-03-29 | Microchips, Inc. | Method and device for the controlled delivery of parathyroid hormone |
US20050287177A1 (en) | 2002-11-08 | 2005-12-29 | Glaxo Group Unlimited And Smithkline Beecham Corp. | Pharmaceutical compositions |
NZ540321A (en) | 2002-11-15 | 2007-09-28 | Tibotec Pharm Ltd | Substituted indolepyridinium as anti-infective compounds |
AU2002350719A1 (en) * | 2002-11-29 | 2004-06-23 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
CL2004000192A1 (es) | 2003-02-07 | 2005-03-18 | Janssen Pharmaceutica Nv | Uso de compuestos derivados de 2-aminopirimidina para preparar un medicamento para la prevencion de una infeccion por vih relaciones sexuales o un contacto intimo en la pareja. |
KR100629771B1 (ko) * | 2004-01-27 | 2006-09-28 | 씨제이 주식회사 | 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법 |
CN102512372A (zh) * | 2004-06-08 | 2012-06-27 | 沃泰克斯药物股份有限公司 | 药物组合物 |
MY191349A (en) | 2004-08-27 | 2022-06-17 | Bayer Pharmaceuticals Corp | New pharmaceutical compositions for the treatment of hyper-proliferative disorders |
AU2005279158C1 (en) | 2004-09-02 | 2010-12-16 | Janssen Pharmaceutica N.V. | Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile |
JP4912309B2 (ja) | 2004-09-02 | 2012-04-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 4−[[4−[[4−(2−シアノエテニル)−2,6−ジメチルフェニル]アミノ]−2−ピリミジニル]アミノ]ベンゾニトリルの塩酸塩 |
WO2006055603A2 (en) | 2004-11-16 | 2006-05-26 | Elan Pharma International Ltd. | Injectable nanoparticulate olanzapine formulations |
TW201414495A (zh) | 2005-04-04 | 2014-04-16 | Tibotec Pharm Ltd | Hiv-感染之預防 |
TW200710091A (en) * | 2005-04-11 | 2007-03-16 | Tibotec Pharm Ltd | (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors |
AU2006235565A1 (en) * | 2005-04-11 | 2006-10-19 | The Board Of Trustees Of The Leland Stanford Junior University | Multi-layer structure having a predetermined layer pattern including an agent |
US20090142401A1 (en) | 2005-06-07 | 2009-06-04 | Leah Elizabeth Appel | Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release |
CN101272769B (zh) * | 2005-07-28 | 2013-04-24 | Isp投资有限公司 | 生物利用度提高的苯醌类化合物 |
MY150717A (en) | 2006-01-20 | 2014-02-28 | Tibotec Pharm Ltd | Long term treatment of hiv-infection with tmc278 |
SI2029110T1 (sl) | 2006-06-06 | 2012-01-31 | Tibotec Pharm Ltd | Z razprševanjem posušeni pripravki TMC125 |
AR061620A1 (es) | 2006-06-23 | 2008-09-10 | Tibotec Pharm Ltd | Suspensiones acuosas de tmc278 |
US20080081064A1 (en) * | 2006-09-28 | 2008-04-03 | Surmodics, Inc. | Implantable Medical Device with Apertures for Delivery of Bioactive Agents |
TWI494133B (zh) | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | 重組用粉末 |
EP2175857B1 (en) | 2007-07-12 | 2013-09-11 | Janssen R&D Ireland | Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
WO2009046299A2 (en) | 2007-10-04 | 2009-04-09 | Boston Scientific Scimed, Inc | Implantable drug depot for intrathecal drug delivery system for pain management |
EP2358198A4 (en) * | 2008-10-24 | 2012-11-14 | Concert Pharmaceuticals Inc | HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES |
-
2008
- 2008-03-13 TW TW097108780A patent/TWI494133B/zh active
- 2008-03-13 CL CL200800746A patent/CL2008000746A1/es unknown
- 2008-03-13 AR ARP080101032A patent/AR065720A1/es not_active Application Discontinuation
- 2008-03-14 KR KR1020097017592A patent/KR101580297B1/ko active IP Right Grant
- 2008-03-14 MX MX2009009743A patent/MX2009009743A/es active IP Right Grant
- 2008-03-14 RU RU2009137911/15A patent/RU2477133C2/ru active
- 2008-03-14 CN CN200880008342.0A patent/CN101636149B/zh active Active
- 2008-03-14 AU AU2008225774A patent/AU2008225774B2/en active Active
- 2008-03-14 JP JP2009553156A patent/JP5554571B2/ja active Active
- 2008-03-14 AP AP2009004969A patent/AP2964A/xx active
- 2008-03-14 CA CA2676981A patent/CA2676981C/en active Active
- 2008-03-14 WO PCT/EP2008/053056 patent/WO2008110619A1/en active Application Filing
- 2008-03-14 ES ES08717800.0T patent/ES2535162T3/es active Active
- 2008-03-14 US US12/530,665 patent/US8916558B2/en active Active
- 2008-03-14 EP EP08717800.0A patent/EP2043608B1/en active Active
- 2008-03-14 BR BRPI0808897A patent/BRPI0808897B8/pt active IP Right Grant
-
2009
- 2009-07-15 IL IL199874A patent/IL199874A/en active IP Right Grant
- 2009-09-11 ZA ZA2009/06344A patent/ZA200906344B/en unknown
-
2019
- 2019-01-21 AR ARP190100128A patent/AR114086A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AP2009004969A0 (en) | 2009-10-31 |
US8916558B2 (en) | 2014-12-23 |
KR101580297B1 (ko) | 2015-12-24 |
TW200911303A (en) | 2009-03-16 |
TWI494133B (zh) | 2015-08-01 |
IL199874A (en) | 2016-02-29 |
JP5554571B2 (ja) | 2014-07-23 |
CN101636149B (zh) | 2014-08-06 |
RU2009137911A (ru) | 2011-04-20 |
AU2008225774A1 (en) | 2008-09-18 |
CA2676981C (en) | 2015-01-13 |
CL2008000746A1 (es) | 2008-09-22 |
BRPI0808897B8 (pt) | 2021-05-25 |
AP2964A (en) | 2014-09-30 |
CN101636149A (zh) | 2010-01-27 |
ZA200906344B (en) | 2015-04-29 |
ES2535162T3 (es) | 2015-05-05 |
RU2477133C2 (ru) | 2013-03-10 |
EP2043608A1 (en) | 2009-04-08 |
US20100120795A1 (en) | 2010-05-13 |
BRPI0808897B1 (pt) | 2020-10-20 |
AU2008225774B2 (en) | 2014-04-10 |
KR20090119964A (ko) | 2009-11-23 |
CA2676981A1 (en) | 2008-09-18 |
BRPI0808897A2 (pt) | 2014-09-02 |
AR065720A1 (es) | 2009-06-24 |
WO2008110619A1 (en) | 2008-09-18 |
MX2009009743A (es) | 2009-09-23 |
IL199874A0 (en) | 2010-04-15 |
JP2010520918A (ja) | 2010-06-17 |
EP2043608B1 (en) | 2015-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR114086A2 (es) | Polvos para reconstitución | |
WO2012006538A8 (en) | Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof | |
ECSP13012382A (es) | Composiciones sólidas | |
BR112013007286A2 (pt) | composição polimérica, película e bolsa de autoclave. | |
CL2011002968A1 (es) | Forma de dosificacion de extrusion por fusion caliente de un ingrediente activo (a) incluido en una matriz que comprende un polimero (c), que el nucleo presenta una orientacion morfologica ortogonal respecto a la direccion longitudinal de extension de la forma de dosificacion; y su procedimiento de preparacion. | |
MX355295B (es) | Artículos para el cuidado personal. | |
NI201000044A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
CL2009000393A1 (es) | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. | |
RS53124B (en) | USE OF BETANECOL FOR THE TREATMENT OF XEROSOMOMY | |
CL2013001723A1 (es) | Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina; metodos de preparacion; composicion farmaceutica; y el uso en el tratamiento de los trastornos mediados por la cinasa de linfoma anaplasico. | |
BRPI1007457A2 (pt) | Conjungado, formulação de liberação prolongada, e, sistema de distribuição de bomba. | |
CR20110553A (es) | Terapia complementaria contra el cáncer | |
CR11417A (es) | Dispositivo de autenticacion de marcado de seguridad | |
PH12015502178A1 (en) | Pyridinylpyrazoloquinoline compound | |
BRPI1013775A2 (pt) | "fixadores laterais cegos propendidos temporários, sistemas e métodos." | |
DOP2010000321A (es) | Derivados de iminopirimidina y su uso | |
BRPI0906168A2 (pt) | Membro fêmea para prendedor de laço e gancho, prendedor de laço e gancho empregado em membro fêmea, e artigo absorvente empregando o prendedor de laço e gancho. | |
BRPI0814576A2 (pt) | Item de calçado, e, métodos para preparar um item de calçado, e para aperfeiçoar o conforto de um item de calçado para o usuário. | |
PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso | |
WO2008145475A8 (en) | Oral care composition | |
AR084487A1 (es) | Componente prostesico con una superficie deslizante que contiene un recubrimiento antimicrobiano | |
AR084982A1 (es) | Conector de transferencia de carga para un conjunto de elementos de soporte | |
WO2009053742A3 (en) | Salts of nefopam and their use in therapy | |
WO2014029888A3 (en) | Branched or macrocyclic polyamines and uses thereof | |
WO2011089435A3 (en) | Device for delivery of an agent through a biological barrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |